R&D Systems抗体
First Rate Antibodies
No Second Guesses

|
活动日期:2009年11月19日至2010年1月19日
活动内容:促销活动期间客户购买R&D Systems公司畅销高品质单克隆抗体产品(MABxxx目录号开头的单抗,并且规格是500ug的),赠送精制不倒翁数码相框一个,如客户自己登陆www.rndsystemschina.com.cn并登记促销期间购买的促销产品,更有机会赢取2张2010年上海世博会门票!
R&D Systems的抗体自主生产,绝大多数选用天然或重组的完整蛋白免疫来制备,保障了产品的高特异性和高亲和力,产品的交叉反应性往往也经过系统的测试并能提供详细的信息。我们提供的多抗产品很多是山羊的抗体,由于每次比兔的单抗产出量高,更能保障产品批次间的一致性。R&D Systems的抗体都经过严格的实验验证,应用范围明确标注,单克隆抗体在体内功能性阻断实验,Western blot,免疫组化IHC,免疫细胞化学ICC等实验中的实验表现颇佳。500ug单克隆抗体更体现了良好的性价比。R&D Systems中国公司能提供本土化技术服务(技术热线:8009881270)和便捷稳定的物流,解除您的后顾之忧。R&D Systems 的抗体特异性好,效价高,性价比优,抗体的应用经过严格的实验验证,每周都有新品推出以满足科学前沿需求。请登录www.rndsystemschina.com.cn查询R&D Systems 的产品。
*本活动最终解释权归本公司
#部分产品及文献应用(需要文献支持,请联系技术热线:8009881270,support@rndsystemschina.com.cn )
| MOLECULE |
DESCRIPTION |
ANTIBODY APPLICATION (KEY) |
CATALOG #/ DATASHEET |
SIZE |
| CD3,CD3 epsilon |
Human CD3 epsilon MAb (Clone UCHT1), Mouse
IgG1
Clone UCHT1 was used by HLDA to establish CD
designation |
FC, FA, IHC, IP |
MAB100 |
500 μg |
 |
Lundqvist, A. et al. Blood.
(2009)113(24):6120-7. Bortezomib treatment and regulatory
T-cell depletion enhance the antitumor effects of adoptively
infused NK cells. |
| MOLECULE |
DESCRIPTION |
ANTIBODY APPLICATION (KEY) |
CATALOG #/ DATASHEET |
SIZE |
| IL-17/IL-17A |
Mouse
IL-17 MAb (Clone 50104), Rat IgG2A |
B/N, WB |
MAB421 |
500 μg |
 |
Luigina, R. et al.Nature. (2008)
451:211. |
| MOLECULE |
DESCRIPTION |
ANTIBODY APPLICATION (KEY) |
CATALOG #/ DATASHEET |
SIZE |
| VEGF |
Human
VEGF MAb (Clone 26503), Mouse IgG2B |
B/N, ELISA(Cap), IHC, WB |
MAB293 |
500 μg |
 |
Gravdal, K. et al. Cancer Res.
(2009)69(11):4708-15. Proliferation of immature tumor vessels
is a novel marker of clinical progression in prostate cancer. |
| MOLECULE |
DESCRIPTION |
ANTIBODY APPLICATION (KEY) |
CATALOG #/ DATASHEET |
SIZE |
| ErbB2/Her2 |
Human ErbB2 MAb (Clone 191924), Mouse IgG2B |
ELISA(Cap), FC, IHC, WB |
MAB1129 |
500 μg |
| ErbB3/Her3 |
Human ErbB3 MAb (Clone 66223), Mouse IgG1 |
B/N, ELISA(Cap), FC |
MAB3481 |
500 μg |
 |
Schoeberl, B. et al. Sci Signal.
(2009) 2(77):ra31.Therapeutically Targeting ErbB3: A Key Node
in Ligand-Induced Activation of the ErbB Receptor–PI3K Axis |
联系我们:
R&D Systems China Co.,Ltd.
地址:上海市长宁区延安西路726号24楼A1座
电话:021-52380373 8009881270
公司网址:www.RnDSystemsChina.com.cn
Email:info@RnDsystemsChina.com.cn
|